6533b858fe1ef96bd12b5b4f
RESEARCH PRODUCT
Noninfectious uveitis: strategies to optimize treatment compliance and adherence.
Manuel Díaz-llopisEmmett T. CunninghamRoberto Gallego-pinazoRosa Dolz-marcoJ. Fernando Arevalosubject
Immunosuppressive treatmentmedicine.medical_specialtynoninfectious uveitisbusiness.industryintraocular inflammationimmunosuppressive treatmentReviewcomplianceBiologic AgentsIntraocular inflammationOphthalmologyInfectious uveitisTreatment successTreatment complianceOphthalmologymedicinetherapeutic failureTherapeutic failureadherenceIntensive care medicinebusinessdescription
Noninfectious uveitis includes a heterogenous group of sight-threatening ocular and systemic disorders. Significant progress has been made in the treatment of noninfectious uveitis in recent years, particularly with regard to the effective use of corticosteroids and non-corticosteroid immunosuppressive drugs, including biologic agents. All of these therapeutic approaches are limited, however, by any given patient's ability to comply with and adhere to their prescribed treatment. In fact, compliance and adherence are among the most important patient-related determinants of treatment success. We discuss strategies to optimize compliance and adherence.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2015-08-01 | Clinical ophthalmology (Auckland, N.Z.) |